← Back to headlines
Charles River Laboratories International Faces Biotech R&D Spending Headwinds
Charles River Laboratories International (CRL) is reportedly facing challenges due to headwinds in biotech research and development spending.
5 Mar, 15:34 — 5 Mar, 15:34
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Philippine DA orders nationwide survey over seed and machinery issues
just now
Aboitiz adds personnel to oversee vehicle flow at Laguindingan Airport
just now
Another firm linked to Nestoil Group gets injunction against EFCC, others
8m ago
CFO Role Expands to Core Business Strategy, Says Professor Wachowiak
12m ago